Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer

Evidence is accumulating for seven and less fractions in localised prostate cancer, including one large randomised trial. However, there is much more evidence yet to come and changing practice in advance of this may be premature. We review the reasons to persist with moderate hypofractionation for p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical oncology (Royal College of Radiologists (Great Britain)) 2020-03, Vol.32 (3), p.175-180
Hauptverfasser:	Tree, A.C., Dearnaley, D.P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Humans Life Sciences & Biomedicine Male Moderate hypofractionation Oncology prostate cancer Prostatic Neoplasms - radiotherapy Radiation Dose Hypofractionation radiotherapy Science & Technology Standard of Care
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Evidence is accumulating for seven and less fractions in localised prostate cancer, including one large randomised trial. However, there is much more evidence yet to come and changing practice in advance of this may be premature. We review the reasons to persist with moderate hypofractionation for prostate cancer radiotherapy, until the results of further phase III studies are known.
ISSN:	0936-6555 1433-2981
DOI:	10.1016/j.clon.2019.10.006